nach oben

Spektrum der Augenheilkunde

Erschienen in:

02.04.2020 | main topic

Effect of repetitive visual training in patients with dry age-related macular degeneration

verfasst von: Dr. Robert Hörantner, Jürgen Wolfsgruber, Gerald Stürzlinger, Michael Ring, Thomas Haslwanter

Erschienen in: Spektrum der Augenheilkunde | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Summary

Purpose

To investigate the efficacy of repetitive visual training with large-field visual stimulation for patients with dry age-related macular degeneration (AMD).

Methods

The Medical Eye Trainer (MET) was tested on 11 patients with unilateral or bilateral dry AMD. The MET consists of a training system for the entire visual system. A moving grating stimulus was presented on a hand-held visual display device (tablet). Repetitive visual training was performed once per day for 90 s, for a total duration of 3 months.

Results

The MET was able to significantly improve visual function after 3 months of use. Eight of the 11 patients reported an improvement in general well-being. No negative effects were reported.

Conclusion

The MET represents an effective additional treatment option for patients with dry AMD, without neglecting well-established treatment methods.

Vorheriger Artikel Fünfzig Jahre Schielbehandlung – Ein Erfahrungsbericht aus Klinik und Praxis

Nächster Artikel Kraniomandibuläre Dysfunktion und Asthenopie – Literaturübersicht mit Fallbeispielen

Fernández-Robredo P, Sancho A, Johnen S, Recalde S, Gama N, Thumann G, et al. Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering. J Ophthalmol. 2014; https://doi.org/10.1155/2014/510285.CrossRefPubMedPubMedCentral

Mantel I, Gillies MC, Souied EH. Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration. Surv Ophthalmol. 2018;63:638–45.CrossRef

Volz C, Pauly D. Antibody therapies and their challenges in the treatment of age-related macular degeneration. Eur J Pharm Biopharm. 2015;95:158–72.CrossRef

Arnold JJ. Age-related macular degeneration: anti-vascular endothelial growth factor treatment. BMJ Clin Evid. 2016;2016:701. http://www.ncbi.nlm.nih.gov/pubmed/26909890, cited 2018 Dec 6.PubMedPubMedCentral

Wang L, Zhang C, Hua R. Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis. Drug Des Devel Ther. 2018;12:3625–33. https://www.dovepress.com/clinical-effectiveness-of-ranibizumab-and-conbercept-for-neovascular-a-peer-reviewed-article-DDDT.CrossRef

Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, et al. The Age-related Eye Disease Study 2 (AREDS2). Ophthalmology. 2012;119:2282–9. https://linkinghub.elsevier.com/retrieve/pii/S0161642012004538.CrossRef

Liew G, Joachim N, Mitchell P, Burlutsky G, Wang JJ. Validating the AREDS simplified severity scale of age-related macular degeneration with 5‑ and 10-year incident data in a population-based sample. Ophthalmology. 2016;123:1874–8.CrossRef

Gorusupudi A, Nelson K, Bernstein PS. The Age-related eye disease 2 study: micronutrients in the treatment of macular degeneration. Adv Nutr. 2017;8:40–53. https://academic.oup.com/advances/article/8/1/40-53/4566582.CrossRef

Crotty M, van den Berg M, Hayes A, Chen C, Lange K, George S. Hemianopia after stroke: a randomized controlled trial of the effectiveness of a standardised versus an individualized rehabilitation program, on scanning ability whilst walking1. NRE. 2018;43:201–9. http://www.medra.org/servlet/aliasResolver?alias=iospress&doi=10.3233/NRE-172377.CrossRef

10.

Holmes JM, Manny RE, Lazar EL, Birch EE, Kelly KR, Summers AI, et al. A randomized trial of binocular dig rush game treatment for amblyopia in children aged 7 to 12 years of age. Ophthalmology. 2018; https://doi.org/10.1016/j.ophtha.2018.10.032.CrossRefPubMedPubMedCentral

11.

Simonsz-Tóth B, Joosse MV, Besch D. Refractive adaptation and efficacy of occlusion therapy in untreated amblyopic patients aged 12 to 40 years. Graefes Arch Clin Exp Ophthalmol. 2018; https://doi.org/10.1007/s00417-018-4170-y.CrossRefPubMed

12.

Frolov AA, Mokienko O, Lyukmanov R, Biryukova E, Kotov S, Turbina L, et al. Post-stroke rehabilitation training with a motor-imagery-based brain-computer interface (BCI)-controlled hand exoskeleton: a randomized controlled multicenter trial. Front Neurosci. 2017;11:400.CrossRef

13.

Georgievski Z, Koklanis K, Leone J. Orthoptists’ management of amblyopia—a case-based survey. Strabismus. 2007;15:197–203. http://www.ncbi.nlm.nih.gov/pubmed/18058356.CrossRef

14.

Bach M, Ullrich D. Contrast dependency of motion-onset and pattern-reversal VEPs: interaction of stimulus type, recording site and response component. Vision Res. 1997;37:1845–9. http://www.ncbi.nlm.nih.gov/pubmed/9274769.CrossRef

15.

Vottonen P, Kaarniranta K, Pääkkönen A, Tarkka IM. Visual processing in patients with age-related macular degeneration performing a face detection test. Clin Ophthalmol. 2017;11:1245–52. https://www.dovepress.com/visual-processing-in-patients-with-age-related-macular-degeneration-pe-peer-reviewed-article-OPTH.CrossRef

16.

O’Brien J, Bloomfield SA. Plasticity of retinal gap junctions: roles in synaptic physiology and disease. Annu Rev Vis Sci. 2018;4:79–100. https://doi.org/10.1146/annurev-vision-091517-034133.CrossRefPubMed

17.

Jones BW, Marc RE, Pfeiffer RL. Retinal degeneration, remodeling and plasticity. In: Kolb H, Fernandez E, Nelson R R, editors. Source webvision: the organization of the retina and visual system. Salt Lake City: University of Utah Health Sciences Center; 1995.

18.

Taylor DJ, Smith ND, Crabb DP. Searching for objects in everyday scenes: measuring performance in people with dry age-related macular degeneration. Investig Opthalmol Vis Sci. 2017;58:1887.CrossRef

19.

Bouws J, Pauleikhoff D, Lemmen KD, Heimes B, Adolphs C. Analysis of anti-VEGF Intravitreal injection treatment in clinical practice. Klin Monbl Augenheilkd. 2016;233:1049–55. https://doi.org/10.1055/s-0042-107153.CrossRefPubMed

20.

Wiesinger K, Reinelt P, Ennemoser A, Edelmayr M, Schönherr U. Was bringt die Anti-VEGF-Therapie im Klinikalltag? Ophthalmologe. 2017;114:639–45. https://doi.org/10.1007/s00347-016-0389-3.CrossRefPubMed

21.

Balasubramanian R, Gan L. Development of retinal amacrine cells and their dendritic stratification. Curr Ophthalmol Rep. 2014;2:100–6.CrossRef

22.

Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, et al. Subthreshold nanosecond laser intervention in age-related macular degeneration. Ophthalmology. 2018; https://doi.org/10.1016/j.ophtha.2018.09.015.CrossRefPubMed

23.

Robinson DG, Margrain TH, Dunn MJ, Bailey C, Binns AM. Low-level nighttime light therapy for age-related macular degeneration: a randomized clinical trial. Investig Opthalmology Vis Sci. 2018;59:4531. https://doi.org/10.1167/iovs.18-24284.CrossRef

24.

Oswald J, Baranov P. Regenerative medicine in the retina: from stem cells to cell replacement therapy. Ther Adv Ophthalmol. 2018; https://doi.org/10.1177/2515841418774433.CrossRefPubMedPubMedCentral

Titel: Effect of repetitive visual training in patients with dry age-related macular degeneration
verfasst von: Dr. Robert Hörantner
Jürgen Wolfsgruber
Gerald Stürzlinger
Michael Ring
Thomas Haslwanter
Publikationsdatum: 02.04.2020
Verlag: Springer Vienna
Erschienen in: Spektrum der Augenheilkunde / Ausgabe 1/2021
Print ISSN: 0930-4282
Elektronische ISSN: 1613-7523
DOI: https://doi.org/10.1007/s00717-020-00451-9

Springer Medizin Österreich

Summary

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

„Spektrum der Augenheilkunde“ – Publisher’s Report 2020

Vertikale Blickparesen bei dorsalem Mittelhirnsyndrom und anderen Erkrankungen

Kraniomandibuläre Dysfunktion und Asthenopie – Literaturübersicht mit Fallbeispielen

Fünfzig Jahre Schielbehandlung – Ein Erfahrungsbericht aus Klinik und Praxis

Mindestanforderungen an das Sehvermögen für das Lenken von Kraftfahrzeugen und Einfluss von Prismenfolien auf das Sehvermögen

Grenzen und Möglichkeiten des Lang-Stereotests